UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Global dynamics of SARS-CoV-2 clades and their relation to COVID-19 epidemiology

Scientific reports, 2021-04, Vol.11 (1), p.8435-8435, Article 8435

2021

Volltextzugriff (PDF)

Calli Essential Oils Synergize with Lawsone against Multidrug Resistant Pathogens

Molecules (Basel, Switzerland), 2017-12, Vol.22 (12), p.2223

2017

Volltextzugriff (PDF)

Design and statistical optimisation of emulsomal nanoparticles for improved anti-SARS-CoV-2 activity of N-(5-nitrothiazol-2-yl)-carboxamido candidates: in vitro and in silico studies

Journal of enzyme inhibition and medicinal chemistry, 2023-12, Vol.38 (1), p.2202357-2202357

2023

Volltextzugriff (PDF)

Intensification of resveratrol cytotoxicity, pro-apoptosis, oxidant potentials in human colorectal carcinoma HCT-116 cells using zein nanoparticles

Scientific reports, 2022-09, Vol.12 (1), p.15235-13, Article 15235

2022

Volltextzugriff (PDF)

Comparative review of the carbapenems

Drugs (New York, N.Y.), 2007-01, Vol.67 (7), p.1027-1052

2007

Volltextzugriff (PDF)

The impact of Catechol-O-methyl transferase knockdown on the cell proliferation of hormone-responsive cancers

Molecular and cellular endocrinology, 2019-05, Vol.488, p.79-88

2019

Volltextzugriff (PDF)

Recent advances in COVID-19-induced liver injury: causes, diagnosis, and management

Inflammopharmacology, 2024-10, Vol.32 (5), p.2649-2680

2024

Volltextzugriff (PDF)

Role of Exosomes in Breast Cancer Management: Evidence-Based Review

Current cancer drug targets, 2021-01, Vol.21 (8), p.666-675

2021

Volltextzugriff (PDF)

Monte Carlo simulation analysis of ceftobiprole, dalbavancin, daptomycin, tigecycline, linezolid and vancomycin pharmacodynamics against intensive care unit-isolated methicillin-resistant Staphylococcus aureus

Clinical and experimental pharmacology & physiology, 2014-06, Vol.41 (6), p.437-443

2014

Volltextzugriff (PDF)

Inhibition of Pseudomonas aeruginosa PAO1 adhesion to and invasion of A549 lung epithelial cells by natural extracts

Journal of infection and public health, 2014-09, Vol.7 (5), p.436-444

2014

Volltextzugriff (PDF)

Pharmacokinetics and pharmacodynamics of the new fluoroquinolones: focus on respiratory infections

Current Opinion in Pharmacology, 2001-10, Vol.1 (5), p.459-463

2001

Volltextzugriff (PDF)

Ceftaroline pharmacodynamic activity versus community-associated and healthcare-associated methicillin-resistant Staphylococcus aureus, heteroresistant vancomycin-intermediate S. aureus, vancomycin-intermediate S. aureus and vancomycin-resistant S. aureus using an in vitro model

Journal of antimicrobial chemotherapy, 2011-06, Vol.66 (6), p.1301-1305

2011

Volltextzugriff (PDF)

Moxifloxacin in lower respiratory tract infections: in silico simulation of different bacterial resistance and drug exposure scenarios

Journal of chemotherapy (Florence), 2014-04, Vol.26 (2), p.80-85

2014

Volltextzugriff (PDF)

Ceftobiprole: A Review of a Broad-Spectrum and Anti-MRSA Cephalosporin

American journal of clinical dermatology, 2008-01, Vol.9 (4), p.245-254

2008

Volltextzugriff (PDF)

Levofloxacin in the treatment of community-acquired pneumonia

Expert review of anti-infective therapy, 2010-05, Vol.8 (5), p.505-514

2010

Volltextzugriff (PDF)

Assessment of the activity of ceftaroline against clinical isolates of penicillin-intermediate and penicillin-resistant Streptococcus pneumoniae with elevated MICs of ceftaroline using an in vitro pharmacodynamic model

Journal of antimicrobial chemotherapy, 2012-07, Vol.67 (7), p.1706-1711

2012

Volltextzugriff (PDF)

Pharmacodynamic activity of ceftobiprole compared with vancomycin versus methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-intermediate Staphylococcus aureus (VISA) and vancomycin-resistant Staphylococcus aureus (VRSA) using an in vitro model

Journal of antimicrobial chemotherapy, 2009-08, Vol.64 (2), p.364-369

2009

Volltextzugriff (PDF)

Use of pharmacodynamic principles to optimise dosage regimens for antibacterial agents in the elderly

Drugs & aging, 2007-01, Vol.24 (4), p.275-292

2007

Volltextzugriff (PDF)

Comparative pharmacodynamics of garenoxacin, gemifloxacin, and moxifloxacin in community-acquired pneumonia caused by Streptococcus pneumoniae : A Monte Carlo simulation analysis

Clinical therapeutics, 2007-12, Vol.29 (12), p.2685-2689

2007

Volltextzugriff (PDF)

Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and Multidrug-Resistant Gram-Negative Bacilli

Drugs (New York, N.Y.), 2019-02, Vol.79 (3), p.271-289

2019

Volltextzugriff (PDF)

Pharmacodynamic target attainment potential of azithromycin, clarithromycin, and telithromycin in serum and epithelial lining fluid of community-acquired pneumonia patients with penicillin-susceptible, intermediate, and resistant Streptococcus pneumoniae

International journal of infectious diseases, 2009-07, Vol.13 (4), p.483-487

2009

Volltextzugriff (PDF)

Pharmacodynamic activity of ertapenem versus multidrug-resistant genotypically characterized extended-spectrum β-lactamase-producing Escherichia coli using an in vitro model

Journal of antimicrobial chemotherapy, 2008-03, Vol.61 (3), p.643-646

2008

Volltextzugriff (PDF)

Hepatitis B vaccination for patients with chronic renal failure

Cochrane database of systematic reviews, 2004-07, Vol.2010 (3), p.CD003775

2004

Volltextzugriff (PDF)

Comparison of gatifloxacin and levofloxacin administered at various dosing regimens to hospitalised patients with community-acquired pneumonia: pharmacodynamic target attainment study using North American surveillance data for Streptococcus pneumoniae

International journal of antimicrobial agents, 2005-08, Vol.26 (2), p.120-125

2005

Volltextzugriff (PDF)

A Review of New Fluoroquinolones : Focus on their Use in Respiratory Tract Infections

Treatments in respiratory medicine, 2006, Vol.5 (6), p.437-465

2006

Volltextzugriff (PDF)

1 – 25 von 42

Suche als RSS-Feed

Aktive Filter

ThemaHumans

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(40)
Mit Volltextzugriff
(33)

Publikationsform

Artikel
(42)

Sprache

Englisch
(42)

Erscheinungsjahr

n.n

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Global dynamics of SARS-CoV-2 clades and their relation to COVID-19 epidemiology

Calli Essential Oils Synergize with Lawsone against Multidrug Resistant Pathogens

Design and statistical optimisation of emulsomal nanoparticles for improved anti-SARS-CoV-2 activity of N-(5-nitrothiazol-2-yl)-carboxamido candidates: in vitro and in silico studies

Intensification of resveratrol cytotoxicity, pro-apoptosis, oxidant potentials in human colorectal carcinoma HCT-116 cells using zein nanoparticles

Comparative review of the carbapenems

The impact of Catechol-O-methyl transferase knockdown on the cell proliferation of hormone-responsive cancers

Recent advances in COVID-19-induced liver injury: causes, diagnosis, and management

Role of Exosomes in Breast Cancer Management: Evidence-Based Review

Monte Carlo simulation analysis of ceftobiprole, dalbavancin, daptomycin, tigecycline, linezolid and vancomycin pharmacodynamics against intensive care unit-isolated methicillin-resistant Staphylococcus aureus

Inhibition of Pseudomonas aeruginosa PAO1 adhesion to and invasion of A549 lung epithelial cells by natural extracts

Pharmacokinetics and pharmacodynamics of the new fluoroquinolones: focus on respiratory infections

Ceftaroline pharmacodynamic activity versus community-associated and healthcare-associated methicillin-resistant Staphylococcus aureus, heteroresistant vancomycin-intermediate S. aureus, vancomycin-intermediate S. aureus and vancomycin-resistant S. aureus using an in vitro model

Moxifloxacin in lower respiratory tract infections: in silico simulation of different bacterial resistance and drug exposure scenarios

Ceftobiprole: A Review of a Broad-Spectrum and Anti-MRSA Cephalosporin

Levofloxacin in the treatment of community-acquired pneumonia

Assessment of the activity of ceftaroline against clinical isolates of penicillin-intermediate and penicillin-resistant Streptococcus pneumoniae with elevated MICs of ceftaroline using an in vitro pharmacodynamic model

Pharmacodynamic activity of ceftobiprole compared with vancomycin versus methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-intermediate Staphylococcus aureus (VISA) and vancomycin-resistant Staphylococcus aureus (VRSA) using an in vitro model

Use of pharmacodynamic principles to optimise dosage regimens for antibacterial agents in the elderly

Comparative pharmacodynamics of garenoxacin, gemifloxacin, and moxifloxacin in community-acquired pneumonia caused by Streptococcus pneumoniae : A Monte Carlo simulation analysis

Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and Multidrug-Resistant Gram-Negative Bacilli

Pharmacodynamic target attainment potential of azithromycin, clarithromycin, and telithromycin in serum and epithelial lining fluid of community-acquired pneumonia patients with penicillin-susceptible, intermediate, and resistant Streptococcus pneumoniae

Pharmacodynamic activity of ertapenem versus multidrug-resistant genotypically characterized extended-spectrum β-lactamase-producing Escherichia coli using an in vitro model

Hepatitis B vaccination for patients with chronic renal failure

Comparison of gatifloxacin and levofloxacin administered at various dosing regimens to hospitalised patients with community-acquired pneumonia: pharmacodynamic target attainment study using North American surveillance data for Streptococcus pneumoniae

A Review of New Fluoroquinolones : Focus on their Use in Respiratory Tract Infections

Aktive Filter

Suchergebnisse filtern